OSIA
ELV icon

O'Shares Investment Advisers’s Elevance Health ELV Stock Holding History

O'Shares Investment Advisers’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,995
Closed -$1.14M – 295
2021
Q2 		$1.14M Buy
2,995
+72
+2% +$27.5K 0.08% 197
2021
Q1 		$1.05M Sell
2,923
-9
-0.3% -$2.89K 0.08% 197
2020
Q4 		$941K Buy
2,932
+261
+10% +$80.1K 0.07% 188
2020
Q3 		$717K Buy
+2,671
New +$719K 0.07% 196

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

O'Shares Investment Advisers's ELV Position: Q3 2021 in Review

O'Shares Investment Advisers sold out of Elevance Health (ELV) in Q3 2021, closing a stake of 2,995 shares — an estimated $1.14M sold.

O'Shares Investment Advisers first reported a position in ELV in Q3 2020 and held it in 4 quarters. The position peaked at $1.14M in Q2 2021. 1,215 funds tracked by Wall St. Rank hold ELV as of Q3 2021.

  • O'Shares Investment Advisers reported no remaining Elevance Health position as of Q3 2021 after selling out during the quarter.
  • O'Shares Investment Advisers sold 2,995 Elevance Health shares in Q3 2021, an estimated $1.14M.
  • O'Shares Investment Advisers first reported a position in Elevance Health in Q3 2020 and held it in 4 quarters.
  • O'Shares Investment Advisers's Elevance Health position peaked at $1.14M in Q2 2021.
  • 1,215 funds tracked by Wall St. Rank held Elevance Health as of Q3 2021.

Based on O'Shares Investment Advisers's 13F filing for Q3 2021, filed 5 Nov 2021.